Journals / Retina-Vitreus / 2017 / Cilt: 26 - Sayı: 2

Short-term Effi ciency of (577-nm) Subthreshold Yellow Laser on Treatment of Chronic Central Serous Chorioretinopathy

Kronik Santral Seröz Koryoretinopati Tedavisinde Eşik Altı Micropulse Sarı Lazerin (577 nm) Kısa Dönem Etkinliği

Pages
133–137
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The anatomic improvement has been achieved in most of the cases, however the functional results was not successful.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate effi ciency and safety of 577-nm subthreshold yellow laser on treatment of chronic central serous chorioretinopathy (CSCR).
📊
Key Findings & Data:Method: Twelve eyes of 12 patients with CSCR were included in this retrospective study.
💡
Conclusion & Impact:The anatomic improvement has been achieved in most of the cases, however the functional results was not successful.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate effi ciency and safety of 577-nm subthreshold yellow laser on treatment of chronic central serous chorioretinopathy (CSCR). Method: Twelve eyes of 12 patients with CSCR were included in this retrospective study. Patients were seen at month1 and month3 after treatment. Best-corrected visual acuity (BCVA), central macular thickness (CMT), subfoveal choroidal thickness (SCT), and height of subretinal fl uid were compared before and after treatment. Results: The mean age was 44.6±13.4 years. 4 patients were female and 8 patients were male. The mean times between patient's symptoms started and the laser treatment was 7.4±1.7 months. The mean BCVA was 0.23 ± 0.13 logMAR at baseline and changed to 0.21 ± 0.13 logMAR at month3 (P=0.43). The mean CMT was 400±93 ?m at baseline and changed to 364±103 ?m at month3 (P=0.29). The mean SCT was 418±89 ?m at baseline and changed to 430±76 ?m at month3 (P=0,14). The mean height of subretinal fl uid was 243±97 ?m at baseline and changed to 151±112 ?m at month3 (P=0,01). Conclusion: The effi ciency of 577-nm subthreshold yellow laser treatment for chronic central serous chorioretinopathy was found limited. The anatomic improvement has been achieved in most of the cases, however the functional results was not successful.

Özet

Amaç: Kronik santral seröz koryoretinopati (SSKR) tedavisinde 577-nm eşik altı sarı lazer tedavisinin etkinliğini ve güvenirliliğini değerlendirmek. Metot: Kronik SSKR'li 12 hastanın 12 gözü geriye dönük olarak çalışmaya alındı. Tüm hastalar 577-nm eşik altı sarı lazer ile tedavi edildi. Hastalar tedavi sonrası takipleri 1. ve 3. ayda yapıldı. Tedavi öncesi ve tedavi sonrası en iyi düzeltilmiş görme keskinliği (EİDGK), merkezi maküla kalınlığı (MMK), subfoveal koroid kalınlığı (SKK) ve retina altı sıvı yüksekliğinde ki değişimler değerlendirildi. Sonuçlar: Hastaların ortalama yaşı 44.6±13.4 yıl idi. Hastaların 4'ü kadın, 8'i erkekti. Semptomların başlamasından lazer tedavisine kadar geçen süre 7.4±1.7 ay idi. Tedavi öncesi ortalama EİDGK 0.23±0.13 logMAR iken, 3.ayda ortalama 0.21±0.13 logMAR idi (P=0.43). Tedavi öncesi ortalama MMK'lığı 400±93 ?m iken, 3.ayda ortalama 364±103 ?m idi (P=0.29). Tedavi öncesi ortalama SKK'lığı 418±89 ?m iken, 3.ayda ortalama 430±76 ?m idi (P=0.14). Retina altı sıvı yüksekliği tedavi öncesi 243±97 ?m iken, tedavi sonrası 3.ayda ortalama 151±112 ?m idi (P=0.01). Tartışma: Eşik altı 577-nm micropulse sarı lazer tedavisinin kronik SSRP tedavisinde etkinliği sınırlıdır. Erken dönemde olguların büyük kısmında anatomik düzelme elde edilirken fonksiyonel sonuçlar başarılı bulunmamıştır.

🔖

Cite This Article

BAZ, Ö., YILMAZ, İ., ALAGÖZ, C., YAZICI, A. T., ÖZKAYA, A., TAŞKAPILI, M. (2017). Short-term Effi ciency of (577-nm) Subthreshold Yellow Laser on Treatment of Chronic Central Serous Chorioretinopathy. Retina-Vitreus, Cilt: 26 - Sayı: 2, 133–137. https://ajindex.com/articles/304947

References (12)

  1. Spaide RF, Goldbaum M, Wong DWK, Tang KC, Iida T. Serous detachment of the retina. Retina 2003;23:820-846
  2. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D. Digital indocyanine gren video angiography of central serous chorioretinopathy. Arch Ophthalmol 1994;112:1057-1062
  3. Yannuzzi LA. Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 2010;149:361-363
  4. Ober MD, Yannuzzi LA, Do DV, Spaide RF, Bressler NM, Jampol LM et al. Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology 2005;112:2088-94
  5. Khosla PK, Rana SS, Tewari HK, Azad RU, Talwar D. Evaluation of visual function following argon laser photocoagulation in central serous retinopathy. Ophthalmic Surg Lasers 1997;28:693-697
  6. Chung YR, Seo EJ, Lew HM, Lee KH. Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review. Eye 2013;27(12):1339-1346
  7. Lanzetta P, Furlan F, Morgante L, Veritti D, Bandello F. Non-visible sub-threshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study. Eur J Ophthalmol 2008;18(6):934-940
  8. Ricci F, Missiroli F, Regine F, Grossi M, Dorin G. Indocyanine gren enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2009;247(5):597-607
  9. Yadav NK, Jayadev C, Mohan A, Vijayan P, Battu R, Dabir S, Shetty B and Shetty R Subthreshold micropulse yellow laser (577nm) in chronic central serous chorioretinopathy: safety profi le and treatment outcome. Eye 2015;29:258-265
  10. Lanzetta P, Dorin G, Pirracchio A, Bandello F. Theoretical bases of non-ophthalmoscopically visible end point photocoagulation. Semin Ophthalmol 2001;16(1):8-11
  11. Bandello F, Lanzetta P, Furlan F, Polito A. Non visible subthreshold micropulse diode laser treatment of idiopathic central serous chorioretinopathy. A pilot study. Invest Ophthalmol Vis Sci. 2003;44:485 12. Chen SN, Hwang JF, Tseng LF, Lin CJ. Sub-threshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. Ophthalmology 2008;115(12):2229-2234
  12. Abd Elhamid AH. Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy. ClinOphthalmol. 2015;3;9:2277-83 14. Kim JY, Park HS, Kim SY. Short-term effi cacy of subthreshold micropulse y